| # | Drug | Count |
|---|---|---|
| 0 | LORAZEPAM | 7 |
| 1 | APIXABAN | 6 |
| 2 | ESOMEPRAZOLE | 5 |
| 3 | ESOMEPRAZOLE MAGNESIUM | 5 |
| 4 | LOPERAMIDE HCL | 5 |
| 5 | LOPERAMIDE HYDROCHLORIDE | 5 |
| 6 | LOPERAMIDE HYDROCHLORIDE ORAL | 5 |
| 7 | MACITENTAN | 5 |
| 8 | TADALAFIL | 5 |
| 9 | IMATINIB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MACITENTAN AND TADALAFIL | 1 | 0.0400 |
| 1 | LOPERAMIDE HCL | 5 | 0.0004 |
| 2 | GLUCAGON | 1 | 0.0002 |
| 3 | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | 0.0002 |
| 4 | SOTATERCEPT-CSRK | 1 | 0.0002 |
| 5 | TROFINETIDE | 1 | 0.0001 |
| 6 | PYRIDOSTIGMINE BROMIDE | 1 | 0.0001 |
| 7 | DRONABINOL | 1 | 0.0001 |
| 8 | LOPERAMIDE HYDROCHLORIDE | 5 | 0.0001 |
| 9 | CLADRIBINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 1 | Cannabinoid [EPC] | 1 | 0.0001 |
| 2 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 7 | 0.0001 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 5 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Endothelin Receptor Antagonist [EPC] | 8 | 0.0000 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 3 | 0.0000 |
| 9 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |